P hosphoinositide 3-kinase (PI3K) signaling is an important pathway in diverse human cancers, and drugs that target the PI3K pathway are currently in clinical trials for the treatment of patients with several cancers, including liver hepatocellular carcinoma (HCC). (1, 2) Drugs that can inhibit all PI3K isoforms are poorly tolerated, and it is difficult to predict which patient populations are suitable for such drugs. (3, 4) The field is therefore moving toward targeting individual class I PI3K isoforms for cancer treatment. (3) (4) (5) Association of the PI3K catalytic subunits (PI3Kα, PI3Kβ, PI3Kδ, and PI3Kγ) with their p85 or p101 regulatory subunit determines the activities of class I 
PI3Ks
. (6, 7) Whereas PI3Kα and PI3Kβ are ubiquitously expressed, PI3Kδ and PI3Kγ are typically expressed in cells of hematopoietic origin. (7) This expression pattern explains the focus of studies on PI3Kα and PI3Kβ in numerous HCC studies. (1, 2, 6) PIK3CA, the gene encoding PI3Kα, shows a 4% gene-alteration rate (including both somatic mutations and gene amplification) in HCC (based on data from the Cancer Genome Atlas [TCGA] ). (8) PIK3CB, PIK3CD, and PIK3CG, which encode PI3Kβ, PI3Kδ, and PI3Kγ, respectively, exhibit 1% to 4% gene-alteration rates in HCC (data from TCGA) and show very low frequency of activating mutations in human cancers. (4) HCC is the second most frequent cause of cancer-related death worldwide, and both incidence and mortality of HCC is predicted to rise globally. (9) HCC risk factors include hepatitis virus infection, alcohol consumption, nonalcoholic fatty liver disease, diabetes, and obesity. All these risk factors are associated with high reactive oxygen species (ROS) levels. (10, 11) We previously showed an increase in ROS levels during the progression from early-grade to advanced-grade human HCC and demonstrated an HCC-promoting effect of these elevated ROS levels. (12, 13) Hydrogen peroxide (H 2 O 2 ) is known to be a major component of ROS in living organisms. (14) The reduced activity of antioxidant enzymes in HCC tumors may allow for the higher level of H 2 O 2 found in HCC tumors relative to nontumor tissues. (12, 15) Alterations in the metabolic activity of HCC tumor cells that are essential for HCC cell survival and/or proliferation can contribute to the increase in H 2 O 2 levels as by-products of metabolic processes, compared with H 2 O 2 levels in nontumor cells. (10, 14) Notably, we have shown that HCC cells treated with 300 μM of H 2 O 2 reflect the physiological environment of in vivo grade III (GIII) HCC tissues with respect to decreased antioxidant enzyme levels, (12, 15) as well as increased epithelial-to-mesenchymal transition, (12) HCC cell invasion and migration, (12, 13, 15) telomerase reverse transcriptase (TERT) expression, (13) and telomere maintenance. (13) This indicates that subjecting HCC cells to H 2 O 2 mimics the malignant phenotype of GIII HCC. Using this in vivo HCC-mimic system, we analyzed the role of different class I PI3K isoforms in HCC and identified a ROS-dependent PI3Kδ signaling axis in this cancer. Further, we showed that specific inhibition of this signaling axis can inhibit HCC growth. These results could facilitate the development of treatments for patients with HCC.
Materials and Methods

tUMoR SpeCIMeNS
The Seoul National University Institutional Review Board approved all experiments using human tissues (SNUIRB No. E1308/001-035). Additional details are described in the Supporting Information. levels, 8-oxo-2′-deoxyguanosine (8-oxo-dG) levels, and protein carbonyl levels were calculated using a Mann-Whitney U test. Values are mean ± SEM excluding the data from in vivo tumorigenicity assay, HCC tissue, and RNA sequencing. The cell viability data following treatment of idelalisib were plotted, and the half maximal inhibitory concentration (IC 50 ) values were calculated using GraphPad software (GraphPad Software Inc., La Jolla, CA). Survival data were estimated using the Kaplan-Meier method, and differences in survival rates were compared using the log-rank test. Statistical analyses were performed using R software (www.r-project.org) or Prism GraphPad Software version 4.0. All experiments were independently repeated at least three times. Significance values were set at *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001 (NS denotes nonsignificance [P > 0.05]).
otHeR MetHoDS
For tumor specimens, RNA sequencing, H 2 O 2 quantitation assay, in vivo tumorigenicity, immunohistochemistry (IHC), survival analysis, cell culture, small interfering (siRNA)-mediated gene silencing, ectopic expression of hTERT or PI3Kδ plasmids, quantitation of promoter activity, quantitation of cell viability, cytotoxicity, apoptosis, ROS inducer, ROS scavenger, PI3K inhibitor treatments, PI3K activity, telomeric repeat amplification protocol assay, determination of gene expression levels by quantitative PCR, immunoblot analysis, immunofluorescence assay, identification of serpin peptidase inhibitor (SERPINA3) as a PI3Kδ regulator and validation analysis, protein carbonyl assay, primary hepatocytes derived from tumor and nontumor liver samples from HCC patients, immunofluorescence in situ hybridization, and DNA sequencing, please see details in the Supporting Information.
Results
INCReaSeD pI3Kδ pRoteIN eXpReSSIoN IN H 2 o 2 -tReateD HCC CellS aND lIVeR tUMoR tISSUeS
Previous studies showed that human HCC cell lines treated for 4 days with 300 μM H 2 O 2, a major ROS in living organisms, (14) simulate key malignant characteristics of human GIII HCC. (12, 13, 15) To formally address this, we analyzed H 2 O 2 levels in freshly prepared liver tumor cells from patients with GIII HCC and found these to be similar to those in HCC cell lines treated for 4 days with 300 μM H 2 O 2 ( Fig. 1A and Supporting Fig. S1 ). GIII HCC tissues also showed similar levels of ROS levels as HCC cell lines treated with H 2 O 2 , as determined by quantifying the protein carbonyl content and the levels of 8-oxo-dG (Fig. 1B,C) .
We next investigated the effect of 300 μM H 2 O 2 on the viability of HCC and non-HCC cell lines. Interestingly, HCC cells were found to be largely resistant to H 2 O 2 ( Fig. 1D left, Supporting Fig. S2 , and Supporting Movies S1-S4) in contrast to non-HCC cell lines that showed high cytotoxicity, accompanied by cell shrinkage and blebbing ( Fig. 1D right, Supporting Fig. S2 , and Supporting Movies S5-S8). Previous data had shown that treatment with 300 μM H 2 O 2 for 4 days increased PI3K activity in HCC cells, but the contribution of the distinct PI3K isoforms in this increased activity had not been determined. (12) Among the class I PI3K catalytic isoforms, only the level of the PI3Kδ protein was increased in HCC cells ( Fig. 1E and Supporting Fig. S3 ). Due to the low survival rate of non-HCC cells after treatment with 300 μM H 2 O 2 for 4 days, we treated non-HCC cell lines with 100 μM to 200 μM H 2 O 2 and found similar PI3Kδ levels with and without H 2 O 2 treatment (Supporting Fig. S3 ). IHC analysis also showed that PI3Kδ expression was increased in human liver-tumor tissues compared with other PI3K isoforms ( Fig. 1F and Supporting Fig. S4A ). Together, these results suggest that PI3Kδ might be responsible for PI3K activation in both the H 2 O 2 -treated HCC cell lines and in vivo HCC tissues.
SUppReSSIoN oF lIVeR tUMoR pRogReSSIoN IN MICe By a pI3Kδ KINaSe INHIBItoR
To determine the effect of PI3Kδ activity on liver tumor growth in vivo, we performed intrahepatic injection through the portal vein of the human Hep3B or Huh7 HCC cell lines in immuno-deficient mice, followed by oral administration of the PI3Kδ inhibitor idelalisib. The growth of liver tumors and number of liver nodules were significantly inhibited following idelalisib treatment at 25 mg/kg twice daily (BID; in Hep3B-injected mice) or 40 mg/kg BID (in Huh7-injected mice) ( Fig. 2A) . Tumor growth induced by subcutaneous injection of HCC cells was also significantly inhibited following idelalisib treatment (Fig. 2B) . Consistent with the observation that idelalisib induced tumor inhibition ( Fig. 2A,B ), siR-NA-mediated PI3Kδ knockdown also inhibited liver tumor growth in mice (Fig. 2C ). There was no hepatotoxicity in the mice following idelalisib treatment (Supporting Fig. S4B ). Based on a previous report that PI3K/phosphorylated AKT (pAKT)/TERT signaling is critical for HCC cell survival, (13) we tested whether PI3Kδ inhibition decreased TERT expression and cell survival using tumor tissue derived from mice after idelalisib treatment. We found that idelalisib induced a sharp decline in pAKT and TERT expression as well as an increase in cleaved poly (ADP-ribose) polymerase levels (cPARP) (Fig. 2D ,E). These data indicate the effectiveness of idelalisib in inhibiting malignant liver tumor growth in vivo.
eFFeCt oF pI3Kδ aCtIVIty-MeDIateD teRt Up-RegUlatIoN oN HCC Cell SURVIVal
We next performed RNA sequencing (GEO accession number GSE109915), which showed elevated PI3Kδ expression levels among class I, II, and III PI3K isoforms in HCC cells following treatment with 300 μM H 2 O 2 compared with mock-treated HCC cells ( Fig. 3A and Supporting Fig. S5 ). HCC tissues also showed increased PI3Kδ mRNA expression level during malignant liver progression (from early to advanced grade), whereas there were no significant changes in the levels of other class I PI3K isoforms (PI3Kα, PI3Kβ, or PI3Kγ) (Fig. 3B) . Collectively, these results suggest specific roles for PI3Kδ activity in liver tissue following an increase in ROS levels. Similarly, H 2 O 2 treatment increased PI3Kδ activity and reduced the activity of other class I PI3K catalytic isoforms in HCC cells (Fig. 3C ). We also found that levels of p85-(or p101-) PI3K heterodimerization were positively associated with PI3K activity (Supporting Fig. S6A ), which is consistent with previous studies. (16) Moreover, idelalisib blocked H 2 O 2 -mediated PI3K activity, and, interestingly, H 2 O 2 treatment decreased the IC 50 value for idelalisib in HCC cell lines by more than 2-fold as compared with idelalisib treatment alone ( We previously showed that H 2 O 2 -induced PI3K signaling increased TERT expression at both the mRNA and protein level, as well as telomerase activity. (13) Presently, among the PI3K isoforms, only PI3Kδ expression and activity levels were found to be increased by H 2 O 2 treatment (Fig. 3A ,C,D and Supporting Figs. S3 and S5). Thus, these results suggest the role of PI3Kδ as an upstream regulator of TERT. TERT reactivation is an essential step in the progression of multiple tumors, (17, 18) and TERT upregulation is observed in 95% of malignant HCCs. (17) TERT up-regulation increases cell-proliferation and survival rates, whereas TERT down-regulation leads to cell death, including apoptosis. (18) H 2 O 2 -induced PI3Kδ activity increased TERT expression at the mRNA and protein level and increased telomerase activity, whereas inhibition of PI3Kδ activity suppressed this downstream signaling ( Fig. 3E and Supporting Fig. S7A ). Idelalisib or PI3Kδ siRNA induced HCC cell death, effects that could be reversed by TERT overexpression (Fig. 3F and Supporting  Fig. S7B,C) . Taken together, these data suggest a pathway whereby H 2 O 2 stimulates PI3Kδ activity and TERT expression. 
pI3Kδ/teRt SIgNalINg aCtIVatIoN By oXIDatIVely MoDIFIeD SeRpINa3
We next aimed to identify the regulator of PI3Kδ-mediated TERT expression in HCC cells with elevated H 2 O 2 levels. In a previous study, we showed that telomere length is a representative indicator of TERT expression. (13, 19) We therefore sorted H 2 O 2 -treated HCC cells harboring telomeres in the top 20th percentile (long telomeres) and bottom 20th percentile of telomere length (short telomeres) using fluorescence-activated cell sorting with the telomere-binding protein adrenocortical dysplasia protein homolog as a marker, (2) followed by whole-genome mRNA-expression microarray analysis (GEO accession number GSE114004; Fig. 4A ). Among the 19 genes significantly differentially expressed between HCC cells with long and short telomeres (Fig. 4A) , we found that only serpin peptidase inhibitor, clade A member 3 (SERPINA3), affected PI3Kδ mRNA expression (Fig. 4B,C and Supporting Fig. S8 ). SERPINA3 overexpression increased PI3Kδ and TERT expression, without altering the levels of other class I PI3K catalytic isoforms (PI3Kα, PI3Kβ, or PI3Kγ) (Fig. 4B) . siRNA-mediated SERPINA3 knockdown decreased PI3Kδ and TERT expression (Fig. 4C, left) . Additionally, SERPINA3 overexpression could not rescue PI3Kδ depletion-mediated down-regulation of TERT expression (Fig. 4C , middle), suggesting that SERPINA3 is an upstream regulator of PI3Kδ-mediated TERT expression.
We next addressed the mechanism by which SERPINA3 regulates PI3Kδ expression. H 2 O 2 treatment increased SERPINA3 protein levels and decreased ubiquitination of SERPINA3 in HCC cells (Fig. 4C, right) . Protein small-molecule-interaction analysis revealed a direct interaction between H 2 O 2 and SERPINA3 (Fig. 4D) (Fig. 4F) . Additionally, the high levels of ubiquitin bound with SERPINA3 were associated with low levels of PI3Kδ and TERT expression (Fig. 4F) . Overall, these findings indicate that H 2 O 2 induces oxidative modifications of SERPINA3 protein, inhibits polyubiquitination and degradation of SERPINA3, and increases PI3Kδ and TERT expression in HCC cells.
poSItIVe aSSoCIatIoN BetWeeN oXIDIZeD SeRpINa3, pI3Kδ, aND teRt IN HCC tISSUeS
HCC tissues showed increased ROS levels and higher PI3Kδ and TERT mRNA expression levels during malignant progression ( Fig. 3B and Supporting  Fig. S10A ). Moreover, HCC tissues displayed a significant positive correlation between PI3Kδ mRNA and TERT mRNA expression levels (Supporting Fig. S10B ). Therefore, we assessed the significance of the H 2 O 2 →SERPINA3→PI3Kδ→TERT regulatory axis in HCC by investigating a possible association between expression of oxidized SERPINA3, PI3Kδ, and TERT in human HCC tissues. The mRNA and protein levels of PI3Kδ, but not of other class . Mean ± SEM (n = 3). **P < 0.01, ***P < 0.001, and ****P < 0.0001; Student t test. Abbreviations: DMSO, dimethyl sulfoxide; FPKM, fragments per kilobase of transcript per million mapped reads; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; G, grade; NAC, N-acetylcysteine; NS, nonsignificance; POC, percent of control. I PI3K isoforms, positively correlated with TERT levels (Fig. 5A-D and Supporting Fig. S10C,D) . GIII HCC showed a positive correlation between PI3Kδ and TERT expression (Pearson correlation coefficient [R] = 0.6228; 95% confidence interval [CI] = 0.07613-0.8816; P = 0.0305; Fig. 5B ). High levels of PI3Kδ were strongly associated with oxidized SERPINA3 levels in GIII HCC tumors (R = 0.7808; 95% CI = 0.3750-0.9355; P = 0.0027; Fig. 5C ). These results are consistent with the immunofluorescence data showing that tumor cells possessing high levels of PI3Kδ expression also had high levels of TERT expression in GIII HCC tissues (Fig. 5D ). Taken together, these observations support the possibility that elevated oxidized SERPINA3 levels can lead to TERT upregulation through PI3Kδ activation also in GIII HCC tissues.
eFFeCt oF pI3Kδ aCtIVIty oN tUMoR-Cell SURVIVal IN HCC tISSUeS
Next, we showed that in malignant hepatocytes derived from patients with GIII HCC, the inhibition of PI3Kδ activity with idelalisib treatment markedly reduced cell viability in a concentration-dependent manner (Fig. 6A ). PI3Kδ activity in untreated malignant hepatocytes was higher compared with other class I PI3K isoforms (PI3Kα, PI3Kβ, or PI3Kγ) and selectively decreased following idelalisib treatment (Fig. 6A) . After idelalisib treatment, malignant hepatocytes showed a sharp decline in pAKT levels and TERT levels (Fig. 6A) , indicating that the PI3Kδ/AKT/TERT pathway is conserved in HCC tissues. Additionally, more than 50% of the malignant hepatocytes died after exposure to a low dose of idelalisib (0.05-1.00 μM) and thus were more sensitive to idelalisib than HCC cell lines (Huh7 and Hep3B; 20-40 μM) (Fig. 6A and Supporting Fig. S6 ). Idelalisib also increased the number of dead cells and caspase-3/7 activity in malignant hepatocytes, whereas there was no significant difference in cell death in hepatocytes derived from nontumors with or without idelalisib ( Fig. 6A and Supporting Fig. S10E) , showing how idelalisib specifically induces cell death in tumor cells. When malignant hepatocytes were treated with PI3Kδ siRNA, they showed a sharp decline in PI3Kδ activity, pAKT levels, TERT levels, and cell viability as well as an increase in caspase-3/7 activity (Fig. 6B) , which is similar to the effect that idelalisib has on malignant hepatocytes. Moreover, we showed that the repression of PI3Kδ activity increased the number of chromatin bridges and telomere dysfunction-induced foci in malignant hepatocytes (Fig. 6C) , suggesting that the presence of telomere defects and subsequent cytotoxicity were induced by impaired PI3Kδ/TERT signaling. HCC cells, as well as HEK293T cells, showed no difference in pAKT levels after overexpression of WT PI3Kδ compared with overexpression of a PI3Kδ mutant (R38S, D107E, P304S, R405C, A414E, P588H, L647I, L682M, K684R, and E713G) found in human HCC in TCGA and the International Cancer Genome Consortium databases) (Supporting Fig. S10F ), indicating that these HCC PI3Kδ mutations do not appear to be PI3Kδ-activating mutations.
We next determined whether PI3Kδ expression levels correlated with HCC patient survival. HCC patients exhibiting high PI3Kδ expression levels showed poor overall survival rates (OSR), poor recurrence-free survival rates (RFSR), and increased invasion frequency (hazard ratio [HR] = 5.511, 95% CI = 2.401-12.65, P < 0.0001 for OSR using univariate analysis; HR = 6.21, 95% CI = 2.676-14.41, P < 0.0001 for RFSR using univariate analysis; HR = 5.999, 95% CI = 2.099-17.138, P = 0.000822 for OSR using multivariate analysis; HR = 5.616, 95%, CI = 1.976-15.96, P = 0.00120 for RFSR using multivariate analysis; P = 0.040715 for microvessel invasion; and P = 0.013361 for serosa invasion) (Fig.  6D , Table 1 , and Supporting Table S1 ). Decreased OSR and RFSR, as well as increased tumor invasion incidence, are hallmarks of malignant tumors with poor prognosis. These data indicate a critical role of PI3Kδ activity in human HCC.
Discussion
PI3Kδ is associated primarily with hematological tumors (5, 7) with the PI3Kδ adenosine triphosphatecompetitive inhibitor idelalisib having been approved by the United States Food and Drug Administration and the European Medicines Agency to treat relapsed indolent non-Hodgkin's B-cell malignancies. (3, 7) Early data suggested that PI3Kδ can also be expressed at lower levels in nonleukocytes, including breast and melanoma cell lines, opposing phosphatase and tension homolog (PTEN) activity. (20, 21) A recent clinical report also suggested that PI3Kδ is highly expressed in some patients with the aggressive skin cancer, Merkel-cell carcinoma. (22) However, the functional relevance of PI3Kδ expression in solid tumors has not been demonstrated. Here, we show that PI3Kδ is selectively up-regulated in HCC through a mechanism of oxidatively modified SERPINA3 protein-mediated transcriptional activation and suggest that PI3Kδ inhibition is a therapeutic target in HCC. Notably, PI3Kδ inhibition has also been reported to stimulate anticancer immune responses. (5, 23) Therefore, this would mean a potential dual effect of PI3Kδ inhibition in malignant liver cancer, direct anti-HCC activity, as well as indirect immunostimulatory activity.
Several lines of evidence have suggested the particular contribution of PI3Kδ characteristics in human carcinogenesis. (24) (25) (26) (27) Different study groups reported PI3Kδ expression (but not other PI3K isoforms) or high ROS levels as causes of reducing the negative regulator of PI3K PTEN expression. (24, 25) Moreover, PI3Kδ-mediated oncogenic activity can be resistant to inhibitors of the mitogen-activated protein kinase pathway, whereas RAS binding may be dispensable for PI3Kδ-mediated oncogenic activity. (26, 27) These PI3Kδ characteristics highlight the potential value of specific blockade of this PI3K isoform in PI3Kδ-activated cancers. In this study, the high PI3Kδ levels were significantly associated with oxidized SERPINA3 and TERT levels. In particular, only PI3Kδ levels were elevated in H 2 O 2 -treated HCC cells, which mimicked the GIII HCC phenotype. Blockade of PI3Kδ activity using siRNA-mediated PI3Kδ silencing and the PI3Kδ-specific inhibitor idelalisib markedly inhibited ROS-mediated PI3K/AKT/TERT activation, whereas idelalisib treatment significantly suppressed PI3Kδ activity but not the activities of other PI3K isoforms in the HCC cell lines and primary HCC cells. Moreover, RNA-seq and microarray analyses showed that ROS is responsible for cell proliferation, cell motility, cell invasion, cell survival, and angiogenesis (Supporting Fig. S11 ), which are reported to be associated with malignant liver cancer. (9, 10) Thus, these results demonstrate the crucial action of PI3Kδ in malignant liver cancers. We showed that idelalisib treatment caused no hepatotoxicity in immuno-deficient mice (Supporting Fig. S4B ), but clinical trials have reported the hepatotoxicity induced by idelalisib. (28) With observation of this adverse effect, studies on the mechanism of idelalisib-related hepatoxicity, analysis of risk factors for hepatotoxicity, and analysis of alleviating side effects of idelalisib in patients on steroids or immunosuppressants have also been followed. (28, 29) (E) Molecular model illustrating oxidized SERPINA3/PI3Kδ/TERT signaling activation as a critical mechanism for malignant HCC cell survival during liver HCC progression. **P < 0.01, ***P < 0.001, and ****P < 0.0001; Student t test. Abbreviations: DAPI, 4′-6-diamidino-2-phenylindole; DMSO, dimethyl sulfoxide; ox, oxidation; IB, immunoblot; IP, immunoprecipitation; POC, percent of control; TIF, telomere-dysfunction-induced-foci; OS, overall survival. Mean ± SEM (n = 3). Note: Hazard ratios are used to describe the effect of each covariate (risk factor). All HRs are relative to the absence of the clinical or molecular event. Among the 15 clinical parameters (PI3Kδ expression level, grade, alpha-fetoprotein (AFP) level, gender, age, tumor number, tumor size, presence of hepatitis B virus, presence of hepatitis C virus, venous invasion, microvessel invasion, bile duct invasion, serosa invasion, surgical margin invasion, and TERT promoter mutation), the parameters of PI3Kδ expression level, grade, AFP level, tumor size, venous invasion, serosa invasion, and surgical margin invasion were significantly associated with HR. Overall and recurrence-free survival analysis in HCC tissues (n = 91 and 80, respectively). *P < 0.05; **P < 0.01; ***P < 0.001. Abbreviations: AFP, alpha-fetoprotein; HBV, hepatitis B virus; HCV, hepatitis C virus; Inf, infinity.
According to the TCGA and Human Protein Atlas databases, liver cancer, as well as glioma, breast cancer and pancreatic cancer, tends to feature high SERPINA3 protein expression among other human tumors. Human SERPINA3 contains six N-glycosylation sites, and changes in SERPINA3 glycosylation are reported in several human cancers and neurodegenerative disorders. (30) (31) (32) (33) Glycosylation influences protein stability and resistance to proteolysis, and specifically prevents ubiquitin-mediated protein degradation. (33) (34) (35) SERPINA3 reportedly binds to DNA, and the ability of SERPINA3 to bind to DNA is not associated with any recognizable specific DNA-binding motif. (32) Here, we showed that PI3Kδ promoter activity and PI3Kδ expression were increased by oxidized SERPINA3, but not by SERPINA3 mutants lacking oxidation-sensitive residues. Additionally, in the most advanced HCC cases, high oxidized-SERPINA3 expression was found to be associated with high PI3Kδ expression, but not PI3Kα, PI3Kβ, or PI3Kγ expression. Thus, SERPINA3 may be responsible for PI3Kδ transcriptional regulation. Moreover, we showed that elevated ROS levels induced oxidative modifications at specific residues in SERPINA3 protein, inhibited ubiquitin-dependent SERPINA3 degradation, and subsequently, increased PI3Kδ and TERT levels and HCC cell survival rate (Fig. 6E) . A previous study reported decreased PI3Kδ levels following microRNA (miRNA)-7 overexpression in established HCC cells. (36) Mostly, the widespread 3′ untranslated region shortening occurs in cancer cells and it escapes from miRNA-mediated repression. (37) In the present study, we also observed oxidized SERPINA3-mediated PI3Kδ activation without involvement of miRNA-7 (Supporting Fig.  S12 ), demonstrating a role of SERPINA3/PI3Kδ in a pathway. Taken together, our findings suggest that SERPINA3/PI3Kδ/AKT/TERT signaling plays a significant role in liver-cancer progression and that this signaling axis is a potential therapeutic target for the treatment of HCC.
